Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Nadeau

Showing results (361-370 of 387) with videos related to

Pageof 39
Sort By:
Allergy|June 15, 2020
A compendium answering 150 questions on COVID-19 and SARS-CoV-2Carmen Riggioni, Pasquale Comberiati, Mattia Giovannini, et al.
Allergy|October 7, 2024
The epithelial barrier theory and its associated diseasesNa Sun, Ismail Ogulur, Yasutaka Mitamura, et al.
Cell|February 12, 2022
Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccinationKatharina Röltgen, Sandra C A Nielsen, Oscar Silva, et al.
Cell Reports. Medicine|July 15, 2022
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19Dorien Feyaerts, Julien Hédou, Joshua Gillard, et al.
Nature Communications|September 15, 2021
New-onset IgG autoantibodies in hospitalized patients with COVID-19Sarah Esther Chang, Allan Feng, Wenzhao Meng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2025
Evaluating COVID-19 severity prediction and immune dynamics with NULISAseq: Insights from the IMPACC studyKoji Abe, Tyson H Holmes, Tran T Nguyen, et al.
Ebiomedicine|August 11, 2022
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC studyAl Ozonoff, Joanna Schaenman, Naresh Doni Jayavelu, et al.
Research Square|June 30, 2025
Empiric Azithromycin in COVID-19 Impacts the Respiratory Microbiome and Antimicrobial Resistome without Anti-inflammatory BenefitCharles Langelier, Abigail Glascock, Cole Maguire, et al.
The Journal of Allergy and Clinical Immunology. Global|July 25, 2025
Type 2 immune responses are associated with less severe COVID-19 in a hospitalized cohortNaresh Doni Jayavelu, Jingjing Qi, Carly E Milliren, et al.
Medrxiv : the Preprint Server for Health Sciences|February 24, 2025
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factorsNaresh Doni Jayavelu, Hady Samaha, Sonia Tandon Wimalasena, et al.
Pageof 39

Showing results (361-370 of 387) with videos related to

Sort By:
Pageof 39
Allergy|June 15, 2020
A compendium answering 150 questions on COVID-19 and SARS-CoV-2Carmen Riggioni, Pasquale Comberiati, Mattia Giovannini, et al.
Allergy|October 7, 2024
The epithelial barrier theory and its associated diseasesNa Sun, Ismail Ogulur, Yasutaka Mitamura, et al.
Cell|February 12, 2022
Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccinationKatharina Röltgen, Sandra C A Nielsen, Oscar Silva, et al.
Cell Reports. Medicine|July 15, 2022
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19Dorien Feyaerts, Julien Hédou, Joshua Gillard, et al.
Nature Communications|September 15, 2021
New-onset IgG autoantibodies in hospitalized patients with COVID-19Sarah Esther Chang, Allan Feng, Wenzhao Meng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2025
Evaluating COVID-19 severity prediction and immune dynamics with NULISAseq: Insights from the IMPACC studyKoji Abe, Tyson H Holmes, Tran T Nguyen, et al.
Ebiomedicine|August 11, 2022
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC studyAl Ozonoff, Joanna Schaenman, Naresh Doni Jayavelu, et al.
Research Square|June 30, 2025
Empiric Azithromycin in COVID-19 Impacts the Respiratory Microbiome and Antimicrobial Resistome without Anti-inflammatory BenefitCharles Langelier, Abigail Glascock, Cole Maguire, et al.
The Journal of Allergy and Clinical Immunology. Global|July 25, 2025
Type 2 immune responses are associated with less severe COVID-19 in a hospitalized cohortNaresh Doni Jayavelu, Jingjing Qi, Carly E Milliren, et al.
Medrxiv : the Preprint Server for Health Sciences|February 24, 2025
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factorsNaresh Doni Jayavelu, Hady Samaha, Sonia Tandon Wimalasena, et al.
Pageof 39